Skip to main content

Advertisement

Table 1 Patients’ clinical and CMR characteristics

From: Multiparametric cardiovascular magnetic resonance imaging in acute myocarditis: a comparison of different measurement approaches

  Healthy Control Group
(n = 30)
Myocarditis Group
(n = 50)
p Value
Age (y) 36.9 ± 13.5 38 ± 16.3 0.764
Male (%) 23 (77) 37 (74) 0.505
BMI (kg/m2) 25.3 ± 4.1 25.4 ± 5.2 0.937
CMR results
 Symptom onset to CMR (d) 2.9 ± 1.8
 Heart rate (bpm) 68.1 ± 12.4 74.1 ± 15.2 0.170
 LVEF (%) 61.6 ± 4.6 55.3 ± 9.4 0.004
 LVEDV/BSA (ml/m2) 74.3 ± 9.4 78.1 ± 17.1 0.552
 IVST (mm) 9.5 ± 1.6 9.8 ± 1.7 .311
Blood values
 Max. Trop I (ng/ml) 18.9 ± 78.2
 Leucocytes (103/μmL) 6.5 ± 1.7 10.4 ± 4.7 0.001
 C-reactive protein (mg/L) 1.0 ± .8 70.7 ± 99 <0.001
 CK-MB mass 21.4 ± 36.6
 Creatine kinase (U/L) 363.5 ± 489.8
 Haematocrit (%) 41.7 ± 3.9 40.5 ± 5.6 0.304
Number of patients with myocarditis specific parameters (%)
 Fulfilling the LLC (%) 0 (0) 36 (72) <0.001
 T2 ratio/visible edema (%) 2 (7) 33 (66) <0.001
 EGEr/aME (%) 6 (20) 24 (59) 0.001
 LGE (%) 0 (0) 39 (78) <0.001
Myocarditis specific parameters
 T2 SI myocardium 763.5 ± 268.9 893.4 ± 262.7 0.004
 T2 SI skeletal muscle 472.5 ± 157.3 465 ± 132.8 0.826
 T2 ratio 1.6 ± 0.3 1.9 ± 0.4 <0.001
 EGEr 2.3 ± 1.9 3.1 ± 1.8 0.063
 aMe (%) 37.5 ± 18.3 54.4 ± 31.6 0.007
 LGE in % 0 12,1 ± 11.8
  1. BMI body mass index, CK creatine kinase, CMR cardiovascular magnetic resonance, EGEr early gadolinium enhancement ratio, LGE late gadolinium enhancement, LLC Lake Louise Criteria